What is it about?

Here we review Cpd1, a gene cloned in our lab by using differential display of mice during postnatal development. Mouse Anp32e (Acidic leucine-rich nuclear phosphoprotein 32 family, member e: NM_023210, P97822, formerly Cpd1), a protein identified in postnatal cerebellum by differential display, belongs to the superfamily of leucine rich repeat (LRR) proteins and to the Acidic Nuclear Phosphoprotein 32 (ANP32) family of protein phosphatase 2 (PPP2, formerly PP2A) inhibitors. Two families of PPP2 inhibitor proteins have been described, ANP32 and SET, represented by the human proteins ANP32A (NM_006305, formerly LANP, PP32, I1PPP2, PHAPI, MAPM, mapmodulin) and SET (NM_003011, formerly PHAPII, 2PPP2, I2PPP2, TAF-1BETA). Besides their common PPP2 inhibitor activity, described several years ago, these nucleo-cytoplasmic shuttling phosphoproteins have additional and very important functions recently reported. In HeLa cells, ANP32A, SET (isoforms A and B) and ANP32B (APRIL), form a multi-subunit heterocomplex with ELAVL1 (NM_001419, formerly HuR), a protein that stabilizes short-lived mRNAs containing AU-rich elements (AREs). A similar heterocomplex, formed by SET (A and B) and ANP32A as major subunits, possess histone acetyltransferase inhibitory activity (INHAT), and have a role in chromatin remodeling and transcriptional regulation (histone code).

Featured Image

Why is it important?

The possible roles of these multifunctional proteins are discussed here, with emphasis on mouse Anp32e and the cerebellar tissue. Anp32e/Cpd1 was found searching for differentially expressed genes the brain, taken as model the postnatal development of the cerebellum. Ref.: Radrizzani M, Vilá-Ortiz G, Cafferata EG, Di Tella MC, González-Guerrico A, Perandones C, Pivetta OH, Carminatti H, Idoyaga Vargas VP, Santa-Coloma TA. Differential expression of CPD1 during postnatal development in the mouse cerebellum. Brain Res. 2001 Jul 13;907(1-2):162-74. PubMed PMID: 11430900.

Perspectives

It was recently found by other lab that ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1. Xiong Z et al. ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1. Mol Oncol. 2018 Apr 6. doi: 10.1002/1878-0261.12202.

Dr Tomás A. Santa Coloma
Institute for Biomedical Research (BIOMED), CONICET, UCA

Read the Original

This page is a summary of: Anp32e (Cpd1) and related protein phosphatase 2 inhibitors, The Cerebellum, December 2003, Springer Science + Business Media,
DOI: 10.1080/14734220310017212.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page